Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Myotonia Congenita; Paramyotonia Congenita; Myotonic Dystrophy 1Last Updated:March 5, 2019Completed
Condition(s):Paralysis, Hyperkalemic Periodic; Hypokalemic Periodic Paralysis; Paramyotonia CongenitaLast Updated:June 24, 2005Completed
Condition(s):Paramyotonia Congenita; Nondystrophic MyotoniaLast Updated:September 16, 2021Unknown status
Condition(s):Non-dystrophic Myotonias; Paramyotonia Congenita; Myotonia CongenitaLast Updated:January 13, 2015Completed
Condition(s):Nondystrophic Myotonias; Myotonia Congenita; Myotonic DisordersLast Updated:March 6, 2013Completed
Condition(s):Non-Dystrophic MyotoniaLast Updated:February 9, 2024Not yet recruiting
Condition(s):Dystrophia Myotonica Type 1; Myotonia Congenita; Paramyotonia Congenita; Hyperkalemic Periodic Paralysis; Potassium-Aggravated MyotoniaLast Updated:April 25, 2016Completed
Condition(s):Non Dystrophic MyotoniaLast Updated:January 26, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.